Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation Group.

Jeffrey W Brettler, Gloria P Giraldo Arcila, Teresa Aumala, Allana Best, Norm Rc Campbell, Shana Cyr, Angelo Gamarra, Marc G Jaffe, Mirna Jimenez De la Rosa, Javier Maldonado, Carolina Neira Ojeda, Modesta Haughton, Taraleen Malcolm, Vivian Perez, Gonzalo Rodriguez, Andres Rosende, Yamilé Valdés González, Peter W Wood, Eric Zúñiga, Pedro Ordunez
{"title":"Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation Group.","authors":"Jeffrey W Brettler, Gloria P Giraldo Arcila, Teresa Aumala, Allana Best, Norm Rc Campbell, Shana Cyr, Angelo Gamarra, Marc G Jaffe, Mirna Jimenez De la Rosa, Javier Maldonado, Carolina Neira Ojeda, Modesta Haughton, Taraleen Malcolm, Vivian Perez, Gonzalo Rodriguez, Andres Rosende, Yamilé Valdés González, Peter W Wood, Eric Zúñiga, Pedro Ordunez","doi":"10.1016/j.lana.2022.100223","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the Americas, and hypertension is the most significant modifiable risk factor. However, hypertension control rates remain low, and CVD mortality is stagnant or rising after decades of continuing reduction. In 2016, the World Health Organization (WHO) launched the HEARTS technical package to improve hypertension control. The Pan American Health Organization (PAHO) designed the HEARTS in the Americas Initiative to improve CVD risk management, emphasizing hypertension control, to date implemented in 21 countries.</p><p><strong>Methods: </strong>To advance implementation, an interdisciplinary group of practitioners was engaged to select the key evidence-based drivers of hypertension control and to design a comprehensive scorecard to monitor their implementation at primary care health facilities (PHC). The group studied high-performing health systems that achieve high hypertension control through quality improvement programs focusing on specific process measures, with regular feedback to providers at health facilities.</p><p><strong>Findings: </strong>The final selected eight drivers were categorized into five main domains: (1) diagnosis (blood pressure measurement accuracy and CVD risk evaluation); (2) treatment (standardized treatment protocol and treatment intensification); (3) continuity of care and follow-up; (4) delivery system (team-based care, medication refill), and (5) system for performance evaluation. The drivers and recommendations were then translated into process measures, resulting in two interconnected scorecards integrated into the HEARTS in the Americas monitoring and evaluation system.</p><p><strong>Interpretation: </strong>Focus on these key hypertension drivers and resulting scorecards, will guide the quality improvement process to achieve population control goals at the participating health centers in HEARTS implementing countries.</p><p><strong>Funding: </strong>No funding to declare.</p>","PeriodicalId":80307,"journal":{"name":"The Case manager","volume":"13 1 1","pages":"None"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121401/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Case manager","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.lana.2022.100223","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the Americas, and hypertension is the most significant modifiable risk factor. However, hypertension control rates remain low, and CVD mortality is stagnant or rising after decades of continuing reduction. In 2016, the World Health Organization (WHO) launched the HEARTS technical package to improve hypertension control. The Pan American Health Organization (PAHO) designed the HEARTS in the Americas Initiative to improve CVD risk management, emphasizing hypertension control, to date implemented in 21 countries.

Methods: To advance implementation, an interdisciplinary group of practitioners was engaged to select the key evidence-based drivers of hypertension control and to design a comprehensive scorecard to monitor their implementation at primary care health facilities (PHC). The group studied high-performing health systems that achieve high hypertension control through quality improvement programs focusing on specific process measures, with regular feedback to providers at health facilities.

Findings: The final selected eight drivers were categorized into five main domains: (1) diagnosis (blood pressure measurement accuracy and CVD risk evaluation); (2) treatment (standardized treatment protocol and treatment intensification); (3) continuity of care and follow-up; (4) delivery system (team-based care, medication refill), and (5) system for performance evaluation. The drivers and recommendations were then translated into process measures, resulting in two interconnected scorecards integrated into the HEARTS in the Americas monitoring and evaluation system.

Interpretation: Focus on these key hypertension drivers and resulting scorecards, will guide the quality improvement process to achieve population control goals at the participating health centers in HEARTS implementing countries.

Funding: No funding to declare.

在初级医疗实践中改善高血压控制的驱动因素和记分卡:美洲 HEARTS 创新小组的建议。
背景:心血管疾病(CVD)是美洲发病和死亡的主要原因,而高血压是最重要的可改变风险因素。然而,高血压控制率仍然很低,心血管疾病死亡率在持续降低数十年后停滞不前或有所上升。2016 年,世界卫生组织(WHO)推出了 HEARTS 技术包,以改善高血压控制。泛美卫生组织(PAHO)设计了美洲 HEARTS 倡议,以改善心血管疾病风险管理,强调高血压控制,迄今已在 21 个国家实施:方法:为了推动该计划的实施,一个跨学科的从业人员小组参与其中,以选择高血压控制的关键循证驱动因素,并设计一个综合记分卡来监测其在初级保健医疗机构(PHC)的实施情况。该小组研究了通过质量改进计划实现高血压控制的高绩效医疗系统,这些计划侧重于具体的流程措施,并定期向医疗机构的服务提供者提供反馈:最终选定的八个驱动因素分为五个主要领域:(1) 诊断(血压测量准确性和心血管疾病风险评估);(2) 治疗(标准化治疗方案和强化治疗);(3) 持续护理和随访;(4) 交付系统(团队护理、药物补充);(5) 绩效评估系统。然后,将这些驱动因素和建议转化为过程措施,形成两张相互关联的记分卡,纳入美洲 HEARTS 监测和评估系统:重点关注这些关键的高血压驱动因素和由此产生的记分卡,将指导质量改进过程,以实现 HEARTS 实施国参与保健中心的人口控制目标:无资金申报。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信